EUR USD GBP
+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

2016 Analysis of Transfusion Diagnostic Assays, and Strategic Profiles of Leading Suppliers

  • ID: 3494535
  • Report
  • November 2015
  • 280 pages
  • VPG Market Research
1 of 3

FEATURED COMPANIES

  • Abbott
  • Biokit
  • Competitive Assessments
  • Fujirebio
  • Immucor
  • Quest
  • MORE
This 280-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.

The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Contains 280 pages and 6 tables
Note: Product cover images may vary from those shown
2 of 3
Competitive Assessments

- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- CellMark Forensics/LabCorp
- Diagast
- DiaSorin
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Immucor
- Ortho-Clinical Diagnostic
- Proteome Sciences
- Quest
- Quidel
- Roche
- Siemens
- Tecan
- Thermo Fisher/Life Technologies
Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown
Adroll
adroll